Pharming Group N.V. (PHGUF)
Develops protein-based medicines for rare genetic diseases like hereditary angioedema.
$1.18-0.09%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+13.0%
The outlook
PHGUF is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, signaling a downtrend. The stock carries a high trailing P/E of 59.0 relative to current earnings. Analyst coverage appears limited based on available data.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
$919.3M
52-wk high
$2.17
52-wk low
$1.14
50-day avg
$1.24
200-day avg
$1.54
Trailing P/E
59.0